Pages that link to "Q33436890"
Jump to navigation
Jump to search
The following pages link to A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens (Q33436890):
Displaying 5 items.
- Novel Proteasome Inhibitors and Histone Deacetylase Inhibitors: Progress in Myeloma Therapeutics (Q39234159) (← links)
- Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma) (Q58793830) (← links)
- The forgotten class of drugs for multiple myeloma: HDAC inhibitors (Q90012125) (← links)
- Seeking Convergence and Cure with New Myeloma Therapies (Q90669066) (← links)
- Efficacy and toxicity of histone deacetylase inhibitors in relapsed/refractory multiple myeloma: Systematic review and meta-analysis of clinical trials (Q92298135) (← links)